Zobrazeno 1 - 10
of 1 148
pro vyhledávání: '"Atsushi, Kawakami"'
Autor:
Jun Miyata, Hirotomo Yamanashi, Shin-Ya Kawashiri, Sakiko Soutome, Kazuhiko Arima, Mami Tamai, Fumiaki Nonaka, Yukiko Honda, Masayasu Kitamura, Koji Yoshida, Yuji Shimizu, Naomi Hayashida, Shigeru Kawakami, Noboru Takamura, Takashi Sawase, Atsutoshi Yoshimura, Yasuhiro Nagata, Mayumi Ohnishi, Kiyoshi Aoyagi, Atsushi Kawakami, Toshiyuki Saito, Takahiro Maeda
Publikováno v:
Journal of Epidemiology, Vol 34, Iss 5, Pp 254-263 (2024)
In an aging society, it is important to visualize the conditions of people living with diseases or disabilities, such as frailty and sarcopenia, and determine the environmental and genetic factors underlying such conditions. Atherosclerosis and arter
Externí odkaz:
https://doaj.org/article/895c4f5861da472290d5e98ae4285413
Autor:
Toshimasa Shimizu, Shin-ya Nishihata, Hideki Nakamura, Yukinori Takagi, Misa Sumi, Atsushi Kawakami
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Sjögren’s syndrome (SS) is an autoimmune disease characterized by periductal lymphocytic infiltration of the salivary and lacrimal glands. SS also exhibits extra-glandular manifestations and specific autoantibodies. Salivary gland ultraso
Externí odkaz:
https://doaj.org/article/931ef6eb6f0347928ebf2c9995beb554
Autor:
Kunihiro Ichinose, Shuntaro Sato, Takashi Igawa, Momoko Okamoto, Ayuko Takatani, Yushiro Endo, Sosuke Tsuji, Toshimasa Shimizu, Remi Sumiyoshi, Tomohiro Koga, Shin-ya Kawashiri, Naoki Iwamoto, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Nobuyuki Yajima, Ken-Ei Sada, Yoshia Miyawaki, Ryusuke Yoshimi, Yasuhiro Shimojima, Shigeru Ohno, Hiroshi Kajiyama, Shuzo Sato, Michio Fujiwara, Atsushi Kawakami
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-7 (2024)
Abstract Background Previous studies have shown conflicting evidence regarding the incidence of cancer in patients with systemic lupus erythematosus (SLE) compared with that in healthy individuals. Calcineurin inhibitors (CNIs) such as cyclosporine a
Externí odkaz:
https://doaj.org/article/8b489b60467f48bba3b92f09524e6ec3
Autor:
Yusuke Yamasaki, Ichiro Horie, Riyoko Shigeno, Shinpei Nishikido, Toshiyuki Ikeoka, Takuro Hirayama, Yohei Tateishi, Akira Tsujino, Atsushi Kawakami
Publikováno v:
Endocrine Journal, Vol 71, Iss 3, Pp 305-312 (2024)
Coronavirus disease 2019 (COVID-19) due to a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can include various systemic organ disorders including endocrinopathies and neurological manifestations. We report the case of a 65-ye
Externí odkaz:
https://doaj.org/article/71358c655ae74d33a1f8da6bc4569bad
Autor:
Takuya Harada, Yoshikane Kikushige, Toshihiro Miyamoto, Kazuko Uno, Hiroaki Niiro, Atsushi Kawakami, Tomohiro Koga, Koichi Akashi, Kazuyuki Yoshizaki
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Castleman disease (CD) is a rare lymphoproliferative disorder. Among subtypes of CD, idiopathic multicentric CD-not otherwise specified (iMCD-NOS) has a poor prognosis and its pathogenesis is largely unknown. Here we present a xenotransplant
Externí odkaz:
https://doaj.org/article/9f865d2680994d2498a4c67939139386
Autor:
Yu Nakashima, Atsushi Kawakami, Yasushi Ogasawara, Masatoshi Maeki, Manabu Tokeshi, Tohru Dairi, Hiroyuki Morita
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract The lasso peptide MS-271 is a ribosomally synthesized and post-translationally modified peptide (RiPP) consisting of 21 amino acids with D-tryptophan at the C-terminus, and is derived from the precursor peptide MslA. MslH, encoded in the MS-
Externí odkaz:
https://doaj.org/article/30d4da2d31ea4565ae031fba06ccc808
Publikováno v:
Biomedicines, Vol 12, Iss 6, p 1141 (2024)
Idiopathic multicentric Castleman disease (iMCD) and TAFRO syndrome present a variety of symptoms thought to be caused by excessive inflammatory cytokines and chemokines, but the underlying mechanisms are unknown. iMCD is broadly classified into two
Externí odkaz:
https://doaj.org/article/95eae135974244c48b55cb6a72edffc0
Autor:
Toshimasa Shimizu, Shin-ya Kawashiri, Shimpei Morimoto, Yurika Kawazoe, Shohei Kuroda, Rina Kawasaki, Yasuko Ito, Rieko Kiya, Shuntaro Sato, Hiroshi Yamamoto, Atsushi Kawakami
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background Administration of Janus kinase (JAK) inhibitors and biological disease-modifying antirheumatic drugs has dramatically improved even the clinical outcomes in patients with rheumatoid arthritis (RA) and an inadequate response to met
Externí odkaz:
https://doaj.org/article/25a2e315a7824154b75a46afcd9aa87a
Autor:
Naoki Iwamoto, Ko Chiba, Shuntaro Sato, Kazuteru Shiraishi, Kounosuke Watanabe, Nozomi Oki, Akitomo Okada, Tomohiro Koga, Shin-ya Kawashiri, Mami Tamai, Naoki Hosogaya, Masako Furuyama, Makiko Kobayashi, Kengo Saito, Naoki Okubo, Masataka Uetani, Makoto Osaki, Atsushi Kawakami
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-13 (2022)
Abstract Background This exploratory study compared the inhibition of bone erosion progression in rheumatoid arthritis (RA) patients treated with a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab versus csDMARD t
Externí odkaz:
https://doaj.org/article/e6b81c15865b41c7946d79133c2efb95
Publikováno v:
Inflammation and Regeneration, Vol 42, Iss 1, Pp 1-5 (2022)
Abstract The molecular platforms of the innate immune system are essential to recognize pathologic external factors that are crucial to differentiate these danger signals from host motifs. A set of sensors recognizing pathologic factors is present an
Externí odkaz:
https://doaj.org/article/e0c7137b2dfa4646b9b7c10064472925